{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260614539468/en/Mirum-Pharmaceuticals-and-Incyte-Announce-Positive-Pivotal-Phase-2-Results-from-PROGRESS-Study-of-Zilurgisertib-in-Fibrodysplasia-Ossificans-Progressiva", "message": "News view counter 798453 successfully enlarged"}